Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Tongue Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Photosensitivity Disorders 1 Mesothelioma, Malignant 1 Colonic Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma in Situ 1

Interventions

Cholecalciferol 1 1-phenyl-3,3-dimethyltriazene 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Carcinoma in Situ × 1-phenyl-3,3-dimethyltriazene × Clear all

NCT02698293 2022-11-22

PDT Plus Vitamin D3 for Anal Dysplasia

Abramson Cancer Center at Penn Medicine

Phase 1 Withdrawn

Carcinoma in Situ

Data powered by HemOnc (CC BY 4.0) Colophon ⚡